Compare SHAZ & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHAZ | INSP |
|---|---|---|
| Founded | 2024 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2025 | 2018 |
| Metric | SHAZ | INSP |
|---|---|---|
| Price | $76.13 | $57.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $46.67 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.2M | 785.6K |
| Earning Date | 06-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ N/A |
| Revenue | $1,566,631.00 | ★ $82,050,000.00 |
| Revenue This Year | $8,711.27 | $8.02 |
| Revenue Next Year | $587.87 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 257.44 | 62.18 |
| 52 Week Low | $16.55 | $38.91 |
| 52 Week High | $97.48 | $147.03 |
| Indicator | SHAZ | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 60.74 | 57.82 |
| Support Level | $59.80 | $52.37 |
| Resistance Level | $75.84 | $59.40 |
| Average True Range (ATR) | 7.39 | 2.44 |
| MACD | 2.95 | 0.02 |
| Stochastic Oscillator | 95.55 | 50.90 |
SharonAI Holdings Inc is a neocloud operator, purpose-built to power the next generation of artificial intelligence (AI) and high-performance computing (HPC). The Company's infrastructure is architected from the ground up to meet the specific, intensive, and complex demands of modern AI training and inference workloads, machine learning, and Generative AI. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, and SHARON AI Studio. The company's products are: SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, and Machine Learning & Infrastructure. The Company operates in one operating segment, High Performance Compute Services (HPC).
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.